Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma

医学 肝细胞癌 离格 射频消融术 危险系数 比例危险模型 内科学 养生 烧蚀 肿瘤科 放射科 放射治疗 置信区间
作者
Keara English,Nils Patrik Brodin,V. Shankar,Shaoyu Zhu,Nitin Ohri,Yosef S. Golowa,Jacob Cynamon,Sarah Bellemare,Andreas Kaubisch,Milan M. Kinkhabwala,Shalom Kalnicki,Madhur Kumar Garg,Chandan Guha,Rafi Kabarriti
出处
期刊:JAMA network open [American Medical Association]
卷期号:3 (11): e2023942-e2023942 被引量:15
标识
DOI:10.1001/jamanetworkopen.2020.23942
摘要

Importance: Hepatocellular carcinoma (HCC) is a heterogeneous disease with many available treatment modalities. Transarterial chemoembolization (TACE) is a valuable treatment modality for HCC lesions. This article seeks to evaluate the utility of additional ablative therapy in the management of patients with HCC who received an initial TACE procedure. Objective: To compare the overall survival (OS) and freedom from local progression (FFLP) outcomes after TACE alone with TACE that is followed by an ablative treatment regimen using stereotactic body radiation therapy, radiofrequency ablation, or microwave ablation for patients with HCC. Design, Setting, and Participants: This cohort study of 289 adults at a single urban medical center examined survival outcomes for patients with nonmetastatic, unresectable HCC who received ablative therapies following TACE or TACE alone from January 2010 through December 2018. The Lee, Wei, Amato common baseline hazard model was applied for within-patient correlation with robust variance and Cox regression analysis was used to assess the association between treatment group (TACE vs TACE and ablative therapy) and failure time events (FFLP per individual lesion and OS per patient), respectively. In both analyses, the treatment indication was modeled as a time-varying covariate. Landmark analysis was used as a further sensitivity test for bias by treatment indication. Exposures: TACE alone vs TACE followed by ablative therapy. Main Outcomes and Measures: Freedom from local progression and overall survival. Hypotheses were generated before data collection. Results: Of the 289 patients identified, 176 (60.9%) received TACE only and 113 (39.1%) received TACE plus ablative therapy. Ablative therapy included 45 patients receiving stereotactic body radiation therapy, 39 receiving microwave ablation, 20 receiving radiofrequency ablation, and 9 receiving a combination of these following TACE. With a median (interquartile range) follow-up of 17.4 (9.5-29.5) months, 242 of 512 (47.3%) lesions progressed, 211 in the group with TACE alone and 31 in the group with TACE plus ablative therapy (P < .001). Over 3 years, FFLP was 28.1% for TACE alone vs 67.4% for TACE with ablative therapy (P < .001). The 1-year and 3-year OS was 87.5% and 47.1% for patients with lesions treated with TACE alone vs 98.7% and 85.3% for patients where any lesion received TACE plus ablative therapy, respectively (P = .01), and this benefit remained robust on landmark analyses at 6 and 12 months. The addition of ablative therapy was independently associated with OS on multivariable analysis for all patients (hazard ratio, 0.26; 95% CI, 0.13-0.49; P < .001) and for patients with Barcelona clinic liver cancer stage B or C disease (hazard ratio, 0.31; 95% CI, 0.14-0.69; P = .004). Conclusions and Relevance: Adding ablative therapy following TACE improved FFLP and OS among patients with hepatocellular carcinoma. This study aims to guide the treatment paradigm for HCC patients until results from randomized clinical trials become available.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
peek1ove完成签到,获得积分10
刚刚
顺利的磊子完成签到,获得积分20
2秒前
徐徐徐徐完成签到,获得积分10
2秒前
2秒前
吃猫的鱼发布了新的文献求助10
3秒前
共享精神的应助被流星采纳,获得10
3秒前
3秒前
4秒前
冷酷的小鸭子完成签到 ,获得积分10
4秒前
5秒前
mei完成签到,获得积分10
6秒前
hui发布了新的文献求助30
7秒前
Uzma完成签到,获得积分10
8秒前
酷波er的应助被包容映安采纳,获得10
9秒前
科研通AI6.3的应助被奥特赛文采纳,获得10
9秒前
sx完成签到,获得积分10
9秒前
极限001的应助被奥特赛文采纳,获得30
9秒前
9秒前
共享精神的应助被lykkk采纳,获得10
9秒前
健忘白猫发布了新的文献求助20
10秒前
BAEKHYUNLUCKY发布了新的文献求助10
10秒前
粗心的鹏笑完成签到,获得积分10
11秒前
12秒前
sdl发布了新的文献求助10
12秒前
minilysum发布了新的文献求助10
12秒前
13秒前
lilili完成签到,获得积分10
13秒前
希望天下0贩的0的应助被haha采纳,获得10
14秒前
星辰大海的应助被周什么园采纳,获得10
14秒前
zcy发布了新的文献求助10
14秒前
EVE_AElle_Lee完成签到,获得积分10
14秒前
科研通AI65的应助被YC采纳,获得30
14秒前
Hase发布了新的文献求助50
15秒前
搜集达人的应助被壮壮采纳,获得10
15秒前
明理的凛完成签到,获得积分10
16秒前
研友_8KX15L发布了新的文献求助30
16秒前
小鱼小鱼快快游完成签到,获得积分10
17秒前
17秒前
Owen的应助被奋斗小真采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175305
求助须知:如何正确求助?哪些是违规求助? 9567097
关于积分的说明 21790117
捐赠科研通 7769782
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556149
邀请新用户注册赠送积分活动 2477241